drugset / Trial / NCT02133469
PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae
Completed
3281 enrolled
Centers for Disease Control and Prevention, China
Beijing Center for Disease Control and Prevention · collabBeijing Municipal Health Bureau · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
A parallel-group, randomized, open-label study will be performed in subjects receiving PCV7 and subjects receiving controlled vaccine Hib vaccine, to claim the efficacy of PCV7 in the prevention of NP carriage of vaccine-serotype S. pneumoniae (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F combined) in 2 to 5 years old healthy Chinese children.
Timeline
- Start
- 2012-06
- Primary completion
- 2014-04
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ActHIB | Vaccine | — | — |
| Subject | Prevnar 13 | Vaccine | 0.5 ml | Other |